Toxinology Department, Women's and Children’s Hospital, North Adelaide, Australia; Department of Paediatrics and Reproductive Medicine, University of Adelaide School of Medicine, Adelaide, Australia [email protected]

Toxinology Department, Women’s and Children’s Hospital, North Adelaide, Australia; Department of Paediatrics and Reproductive Medicine, University of Adelaide School of Medicine, Adelaide, Australia

J.W. provides advice to the antivenom manufacturer (Seqirus, formerly CSL, Ltd), as part of a contract between his employing hospital and CSL. He is not paid by CSL, and CSL has no input or influence on any of his/our reports, clinical practice, or comments. The other authors report no conflict of interest.